BioCentury
BioCentury This Week
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Be sure to visit the podcast's website and support the creator: www.biocentury.com
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Install for free
Android almost 10M downloads · 4.8 rating
iOS soon
Episodes
Ep 76 Pt. 2 - Standards of Evidence for Accelerated Approval 30.08.2021 14:52
Reach us by sending a text
Ep 76 Pt. 1 - Accelerated Approval's Big Picture 30.08.2021 22:09
Reach us by sending a text
Ep. 75 - Back to School Preview, plus Pfizer Eats Trillium 24.08.2021 22:59
Reach us by sending a text
Ep. 74 - Vertex's Road Map & Innovation in MS 16.08.2021 13:31
Reach us by sending a text
Ep. 73 - Next Up in COVID with Otello Stampacchia and Umer Raffat 13.08.2021 19:05
Reach us by sending a text
Ep. 72 - Modality Matters: M&A Heats Up, Galbraith Maps AZ's BD 09.08.2021 18:27
Reach us by sending a text
Ep. 71 - Lessons from China’s Market Turmoil, Plus Distillery on Tap 03.08.2021 27:03
Reach us by sending a text
Ep. 70 - Prepping for China’s IP law with Jones Day’s Tony Chen 29.07.2021 17:19
Reach us by sending a text
Ep. 69 - Allaying Aduhelm Concerns, Plus Master Protocols, Arvinas-Pfizer 27.07.2021 14:30
Reach us by sending a text
Ep. 68 - Drug Pricing Pressure, Plus European Deal Trends 20.07.2021 26:19
Reach us by sending a text
Ep. 67 - Aduhelm: a Tangled Plot; Plus, INTREPID Pandemic Planning 13.07.2021 32:15
Reach us by sending a text
Ep. 66 - Biotechs hit 3Q with Coolers Full of Cash; plus Distillery on Tap 06.07.2021 21:36
Reach us by sending a text
Ep. 65 - Optimism for Intellia's CRISPR Breakthrough, Concerns about Aduhelm 29.06.2021 22:58
Reach us by sending a text
Ep. 64 - Amyloid Analysis: Stress Testing FDA's Logic on Surrogate Endpoint 24.06.2021 18:43
Reach us by sending a text
Ep. 63 - Woodcock, Noubar and Genmab’s dealmaking: A BioCentury Podcast 21.06.2021 24:46
Reach us by sending a text
Ep. 62 - Reflecting on the Implications of Aduhelm's Approval: A BioCentury Podcast 14.06.2021 18:32
Reach us by sending a text
Ep. 61 - Dissecting FDA's Aducanumab Decision 08.06.2021 25:24
Reach us by sending a text
Ep. 60 - D-Day for Aducanumab: What's at stake 02.06.2021 15:10
Reach us by sending a text
Ep. 59 - KRAS to the Future; plus ARPA-H & EGFR 02.06.2021 23:45
Reach us by sending a text
Ep. 58 - LAG3 Before You Leap; plus BEE21, G20 Highlights 24.05.2021 24:46
Reach us by sending a text
Ep. 57 - Financing Scandinavia; plus IP Waivers, Long Covid & AAV Pays 10.05.2021 28:06
Reach us by sending a text
Ep. 56 - FDA’s ODAC Bind; plus NK Cell Engagers and Company Creation in Europe 04.05.2021 20:37
Reach us by sending a text
Ep. 55 - German Plays Deliver on Data, plus Accelerated Approval on Trial 27.04.2021 19:06
Reach us by sending a text
Ep. 54 - Patient Groups’ Pandemic Pain; plus Voters’ Rights and Synthetic Lethality 20.04.2021 25:51
Reach us by sending a text
Ep. 53 - Competence & Continuity at CDER; plus BIO 3.0, AACR and 2Q Preview 13.04.2021 23:45
Reach us by sending a text
Similar podcasts
Listen to the BioCentury This Week podcast in Replaio
Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.
